Who is Cardea and why do they own Nanosens?
Cardea’s claim to fame is being the first and only company in the world able to mass-produce graphene Biology-gated Transistors on a commercial scale.
What are Biology-gated Transistors?
Biology-gated Transistors, or Cardean Transistors™ are made of the nanomaterial graphene and can, like silicon, be used to build electronic transistors such as those inside all the computer chips running smartphones and computers. Graphene has the extra unique property of being biocompatible – meaning that the “on” and “off” stage of the transistor gate can be switched “on” if a biological signal is present, and “off” if it is not.
This is Cardea’s novel way of making a direct connection between the complex, but precise molecular signals involved in biology with a computer’s logical calculation abilities.
The tech startup Nanosens Innovations Inc. (co-founded by Dr. Kiana Aran and Michael Heltzen) became a fully integrated part of Cardea in Q3 2019 as the two companies agreed that CRISPR-Chip and other Nanosens IP would help more people if it lived inside of Cardea.
Feel welcome to visit www.cardeabio.com to read more about Cardea, our technologies, and our commitment to help create the Internet of Biology.